Yingjun Li

1.3k total citations
58 papers, 971 citations indexed

About

Yingjun Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yingjun Li has authored 58 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Yingjun Li's work include Synthesis and biological activity (7 papers), Cancer therapeutics and mechanisms (6 papers) and Tree-ring climate responses (5 papers). Yingjun Li is often cited by papers focused on Synthesis and biological activity (7 papers), Cancer therapeutics and mechanisms (6 papers) and Tree-ring climate responses (5 papers). Yingjun Li collaborates with scholars based in China, United States and Macao. Yingjun Li's co-authors include Dan R. Halm, Xiaohua Gou, Kun Chen, Ding Ye, Keyan Fang, Zhenhua Ye, Fahu Chen, Jianbing Wang, Mingjuan Jin and Xiaoqin Li and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Yingjun Li

55 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjun Li China 19 382 168 142 136 132 58 971
Elisa Romeo Italy 25 417 1.1× 76 0.5× 25 0.2× 33 0.2× 28 0.2× 62 2.1k
Vivek Panwar India 11 234 0.6× 83 0.5× 169 1.2× 204 1.5× 59 0.4× 19 775
Robert D. Elliott United States 18 319 0.8× 292 1.7× 121 0.9× 117 0.9× 11 0.1× 80 909
Hisashi Suzuki Japan 22 210 0.5× 118 0.7× 12 0.1× 30 0.2× 42 0.3× 79 1.4k
Alexander Kraus Germany 13 212 0.6× 98 0.6× 238 1.7× 104 0.8× 56 0.4× 21 672
Charles E. Cobb United States 19 396 1.0× 64 0.4× 71 0.5× 49 0.4× 21 0.2× 38 1.2k
Kazuo Hirose Japan 20 312 0.8× 71 0.4× 81 0.6× 34 0.3× 84 0.6× 73 1.1k
Barbara Zarzycka Netherlands 17 450 1.2× 88 0.5× 55 0.4× 8 0.1× 48 0.4× 35 768
Michiko Ichimasa Japan 11 311 0.8× 37 0.2× 28 0.2× 167 1.2× 49 0.4× 31 1.3k

Countries citing papers authored by Yingjun Li

Since Specialization
Citations

This map shows the geographic impact of Yingjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Li more than expected).

Fields of papers citing papers by Yingjun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Li. The network helps show where Yingjun Li may publish in the future.

Co-authorship network of co-authors of Yingjun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjun Li. A scholar is included among the top collaborators of Yingjun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjun Li. Yingjun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kun, Konstantin I. Ivanov, Sidi Yang, et al.. (2025). Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses. Acta Pharmaceutica Sinica B. 15(5). 2498–2510. 1 indexed citations
2.
Li, Yingjun, et al.. (2025). Anti-influenza drugs targeting trimeric RNA polymerase complex: From development to clinics. Acta Pharmaceutica Sinica B. 16(2). 728–745.
3.
Chen, Yongzhi, Qifan Zhou, Zhengchao Tu, et al.. (2024). Synthesis and anti-influenza virus activity of substituted dibenzoxepine-based baloxavir derivatives. European Journal of Medicinal Chemistry. 280. 116922–116922. 1 indexed citations
4.
Zhou, Qifan, Sidi Yang, Chao Yang, et al.. (2024). Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection. Bioorganic Chemistry. 153. 107894–107894. 1 indexed citations
5.
Cao, Liu, Jun Zhou, Sidi Yang, et al.. (2023). Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2. Antiviral Research. 213. 105586–105586. 14 indexed citations
6.
Wei, Qi, Qian Qiu, Jiali Ma, et al.. (2023). An iASPP‐derived short peptide restores p53‐mediated cell death in cancers with wild‐type p53. SHILAP Revista de lepidopterología. 1(2). 121–131. 1 indexed citations
7.
Yang, Liping, et al.. (2023). Involvement of the GABAergic system in PTSD and its therapeutic significance. Frontiers in Molecular Neuroscience. 16. 1052288–1052288. 24 indexed citations
8.
Zhou, Qifan, Yinzhu Luo, Yujun Zhu, et al.. (2023). Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses. European Journal of Medicinal Chemistry. 249. 115113–115113. 7 indexed citations
9.
Cheng, Huimin, Liangbing Fu, Xia Yang, et al.. (2022). Screening and identification of 3‐aryl‐quinolin‐2‐one derivatives as antiviral agents against influenza A. Journal of Medical Virology. 95(1). 48–51. 1 indexed citations
10.
Hu, Le’an, Ruxi Qi, Yu Chang, et al.. (2022). Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia. European Journal of Medicinal Chemistry. 244. 114731–114731. 7 indexed citations
11.
Li, Yingjun, Kalyan Kumar Pasunooti, Hanjing Peng, et al.. (2020). Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. ACS Medicinal Chemistry Letters. 11(6). 1111–1117. 4 indexed citations
12.
Li, Yingjun, Xiaoqin Li, Ding Ye, et al.. (2018). Attributable causes of colorectal cancer in China. BMC Cancer. 18(1). 38–38. 114 indexed citations
13.
Chang, Yu, Xiaoyun Lu, Marthandam Asokan Shibu, et al.. (2017). Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors. Journal of Medicinal Chemistry. 60(13). 5927–5932. 20 indexed citations
14.
Ye, Ding, Danjie Jiang, Yingjun Li, Mingjuan Jin, & Kun Chen. (2017). The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis. International Journal of Clinical Oncology. 22(4). 749–757. 22 indexed citations
15.
Jin, Mingjuan, Yingjun Li, Fangyuan Jing, et al.. (2017). Association of a novel genetic variant in RP 11-650 L 12.2 with risk of colorectal cancer in Han Chinese population. Gene. 624. 21–25. 8 indexed citations
16.
Han, Kun, Rong Qu, Linjiang Tong, et al.. (2015). 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFRL858R/T790M. Bioorganic & Medicinal Chemistry Letters. 25(19). 4277–4281. 20 indexed citations
17.
Mao, Yingying, Yingjun Li, Fangyuan Jing, et al.. (2014). Association of a genetic variant in microRNA-146a with risk of colorectal cancer: a population-based case-control study. Tumor Biology. 35(7). 6961–6967. 23 indexed citations
18.
Li, Yingjun, et al.. (2012). Influence of recombinant thioredoxin on apoptosis of myocardium cell in viral myocarditis of mice. Chin J Endemiol. 31(2). 172–176. 2 indexed citations
19.
Peng, Lijie, Lei Duan, Xiaofeng Liu, et al.. (2011). Structure–activity study on a series of α-glutamic acid scaffold based compounds as new ADAMTS inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4457–4461. 9 indexed citations
20.
Yang, Tao, et al.. (2009). Tree-ring researches over the northwest China: a review. Frontiers of Earth Science in China. 4(2). 181–194. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Romeo Breakdown of academic impact, for papers by Vivek Panwar Breakdown of academic impact, for papers by Robert D. Elliott Breakdown of academic impact, for papers by Hisashi Suzuki Breakdown of academic impact, for papers by Alexander Kraus Breakdown of academic impact, for papers by Charles E. Cobb Breakdown of academic impact, for papers by Kazuo Hirose Breakdown of academic impact, for papers by Barbara Zarzycka Breakdown of academic impact, for papers by Michiko Ichimasa
Rankless by CCL
2026